Study of TNF-Antagonism in Metabolic Syndrome

A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.

NCT01017302 ·Status: COMPLETED ·Phase: PHASE1

ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT05134662 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.

NCT00755846 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

NCT01103414 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

NCT00849017 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus

NCT02916706 ·Status: COMPLETED ·Phase: PHASE3

Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes

NCT03655535 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Albiglutide in Type 2 Diabetes

NCT00849056 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes

NCT01289119 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus

NCT02924064 ·Status: COMPLETED ·Phase: PHASE3

A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects

NCT00162305 ·Status: COMPLETED ·Phase: PHASE2

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

NCT00701935 ·Status: TERMINATED ·Phase: PHASE2

Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to Metformin or Placebo

NCT02682121 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

NCT02798172 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus

NCT00856284 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan

NCT01318109 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy

NCT02068443 ·Status: COMPLETED ·Phase: PHASE3

Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance

NCT00108615 ·Status: COMPLETED ·Phase: PHASE4

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

NCT00286494 ·Status: COMPLETED ·Phase: PHASE3

Explore the Effect of Gynostemma Pentaphyllum on Patients With Metabolic Syndrome

NCT05118698 ·Status: UNKNOWN ·Phase: NA

A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes

NCT00839527 ·Status: COMPLETED ·Phase: PHASE3

A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes Mellitus

NCT00661921 ·Status: WITHDRAWN ·Phase: PHASE2

The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome

NCT00926341 ·Status: COMPLETED ·Phase: PHASE4

Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

NCT02989649 ·Status: TERMINATED

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

NCT00528372 ·Status: COMPLETED ·Phase: PHASE3